Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome--a pilot study
- PMID: 23164226
- DOI: 10.3168/jds.2012-5863
Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome--a pilot study
Abstract
Based on animal studies, intake of probiotic bacteria was suggested to improve insulin sensitivity by reducing endotoxinemia and inflammation. The objective of this study was to determine the effects of supplementation with the probiotic strain Lactobacillus casei Shirota (LcS) over 12 wk on insulin sensitivity, β-cell function, inflammation, and endothelial dysfunction parameters in subjects with metabolic syndrome. In a randomized-controlled study, 30 subjects with metabolic syndrome either received Lactobacillus casei Shirota 3 times daily for 12 wk or served as controls with standard medical therapy. Fasting blood samples were taken and a 75-g oral glucose tolerance test was performed to derive indices for insulin sensitivity and β-cell function. In addition, parameters to assess endothelial function and inflammation markers were determined. Even though the insulin sensitivity index significantly improved after 3 mo of probiotic supplementation (0.058±0.021 vs. 0.038±0.025), the change was not significantly different compared with the control group. No improvements were seen in additional indices of insulin sensitivity (quantitative insulin sensitivity check index, insulin sensitivity by oral glucose tolerance test, and homeostasis model assessment for insulin resistance) and β-cell function (first and second phase insulin secretion, and homeostasis model assessment for β-cell function). Probiotic supplementation resulted in a significant reduction in soluble vascular cell adhesion molecule-1 (sVCAM-1) level (1,614±343 vs. 1,418±265 ng/mL). No significant changes in parameters used to assess low-grade inflammation or endothelial dysfunction were observed. Intake of LcS for 12 wk in subjects with metabolic syndrome did not improve insulin sensitivity, β-cell function, endothelial function, or inflammation markers in this trial.
Copyright © 2013 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.Nutrition. 2016 Mar;32(3):315-20. doi: 10.1016/j.nut.2015.09.003. Epub 2015 Sep 28. Nutrition. 2016. PMID: 26706022 Clinical Trial.
-
Effects of probiotic yogurt on glycemic indexes and endothelial dysfunction markers in patients with metabolic syndrome.Nutrition. 2019 Jun;62:162-168. doi: 10.1016/j.nut.2018.12.011. Epub 2019 Jan 2. Nutrition. 2019. PMID: 30921552 Clinical Trial.
-
Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study.Atherosclerosis. 2015 Sep;242(1):141-4. doi: 10.1016/j.atherosclerosis.2015.05.005. Epub 2015 Jul 8. Atherosclerosis. 2015. PMID: 26188537 Clinical Trial.
-
Biological effects of probiotics: what impact does Lactobacillus casei shirota have on us?Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1 Suppl):45S-50S. Int J Immunopathol Pharmacol. 2011. PMID: 21329565 Review.
-
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness.Crit Rev Microbiol. 2024 Sep;50(5):663-683. doi: 10.1080/1040841X.2023.2257776. Epub 2023 Sep 13. Crit Rev Microbiol. 2024. PMID: 37705353 Review.
Cited by
-
Effects of Probiotics on Inflammatory Biomarkers and Its Associations With Cardiac Autonomic Function in Women With Arterial Hypertension: A Secondary Analysis of a Randomized Clinical Trial.Probiotics Antimicrob Proteins. 2024 Jun 6. doi: 10.1007/s12602-024-10303-6. Online ahead of print. Probiotics Antimicrob Proteins. 2024. PMID: 38842655
-
Insights into the Anti-Adipogenic and Anti-Inflammatory Potentialities of Probiotics against Obesity.Nutrients. 2024 Apr 30;16(9):1373. doi: 10.3390/nu16091373. Nutrients. 2024. PMID: 38732619 Free PMC article. Review.
-
Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome (ABESO-2022).Diabetol Metab Syndr. 2023 Jun 9;15(1):124. doi: 10.1186/s13098-023-01037-6. Diabetol Metab Syndr. 2023. PMID: 37296485 Free PMC article. Review.
-
Nutritional supplements improve cardiovascular risk factors in overweight and obese patients: A Bayesian network meta-analysis.Front Nutr. 2023 Mar 30;10:1140019. doi: 10.3389/fnut.2023.1140019. eCollection 2023. Front Nutr. 2023. PMID: 37063314 Free PMC article.
-
Clinical Evidence on the Potential Beneficial Effects of Probiotics and Prebiotics in Cardiovascular Disease.Int J Mol Sci. 2022 Dec 14;23(24):15898. doi: 10.3390/ijms232415898. Int J Mol Sci. 2022. PMID: 36555535 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical